165 related articles for article (PubMed ID: 19665288)
1. Re: Markus J. Bader, Ronald Sroka, Christian Gratzke, et al. Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 2009;56:65-71.
Matera L
Eur Urol; 2009 Nov; 56(5):e30; author reply e31. PubMed ID: 19665288
[No Abstract] [Full Text] [Related]
2. Re: Markus J. Bader, Ronald Sroka, Christian Gratzke, et al. Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 2009;56:65-71.
Palou J; Rodríguez Ó; Breda A
Eur Urol; 2010 Apr; 57(4):e31-2; author reply e33. PubMed ID: 20006423
[No Abstract] [Full Text] [Related]
3. Laser therapy for upper urinary tract transitional cell carcinoma: indications and management.
Bader MJ; Sroka R; Gratzke C; Seitz M; Weidlich P; Staehler M; Becker A; Stief CG; Reich O
Eur Urol; 2009 Jul; 56(1):65-71. PubMed ID: 19108945
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract.
Zincke H; Neves RJ
Urol Clin North Am; 1984 Nov; 11(4):717-24. PubMed ID: 6506376
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: comparison of laparoscopic and open surgery.
Tsujihata M; Nonomura N; Tsujimura A; Yoshimura K; Miyagawa Y; Okuyama A
Eur Urol; 2006 Feb; 49(2):332-6. PubMed ID: 16387415
[TBL] [Abstract][Full Text] [Related]
6. Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9.
Papatsoris AG; Mitsogiannis I; Deliveliotis C
Eur Urol; 2010 Aug; 58(2):e19. PubMed ID: 20004053
[No Abstract] [Full Text] [Related]
7. Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9.
Ponholzer A; Madersbacher S
Eur Urol; 2010 Jul; 58(1):e9. PubMed ID: 20346579
[No Abstract] [Full Text] [Related]
8. Re: Marco Roscigno, Cesare Cozzarini, Roberto Bertini, et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol 2008;53:794-802.
Chung SD; Yu HJ; Chueh SC
Eur Urol; 2008 Oct; 54(4):953-4. PubMed ID: 18508191
[No Abstract] [Full Text] [Related]
9. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
10. Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma.
Dragicevic D; Djokic M; Pekmezovic T; Vuksanovic A; Micic S; Hadzi-Djokic J; Tulic C; Milenkovic D; Pljesa-Ercegovac M; Simic T
Urol Int; 2009; 82(3):335-40. PubMed ID: 19440024
[TBL] [Abstract][Full Text] [Related]
11. Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches.
Argyropoulos AN; Tolley DA
BJU Int; 2007 May; 99(5):982-7. PubMed ID: 17437430
[No Abstract] [Full Text] [Related]
12. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years.
Berger A; Haber GP; Kamoi K; Aron M; Desai MM; Kaouk JH; Gill IS
J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229
[TBL] [Abstract][Full Text] [Related]
13. Editorial comment on: Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
Cagiannos I
Eur Urol; 2007 Nov; 52(5):1419-20. PubMed ID: 17507149
[No Abstract] [Full Text] [Related]
14. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
[TBL] [Abstract][Full Text] [Related]
15. Re: Maurizio A. Brausi, Mirko Gavioli, Giuseppe De Luca et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol 2007;52:1414-20.
Simone G; Papalia R; Gallucci M
Eur Urol; 2008 Aug; 54(2):467; author reply 468. PubMed ID: 18262332
[No Abstract] [Full Text] [Related]
16. Urothelial carcinoma of the upper urinary tract.
Humphrey PA
J Urol; 2014 Oct; 192(4):1223-4. PubMed ID: 25046603
[No Abstract] [Full Text] [Related]
17. Management of patients with upper urinary tract transitional cell carcinoma.
Raman JD; Scherr DS
Nat Clin Pract Urol; 2007 Aug; 4(8):432-43. PubMed ID: 17673914
[TBL] [Abstract][Full Text] [Related]
18. Upper urinary tract cancer: location is correlated with prognosis.
van der Poel HG; Antonini N; van Tinteren H; Horenblas S
Eur Urol; 2005 Sep; 48(3):438-44. PubMed ID: 16115524
[TBL] [Abstract][Full Text] [Related]
19. The experience of the CHU Liège with conservative surgery in the management of upper urinary tract tumors.
Bouffioux C; Andrianne R; Bonnet P; Boca P; Vaesen R; Baldé S; de Leval J
Acta Urol Belg; 1994 Dec; 62(4):39-43. PubMed ID: 7793346
[TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
